Product NDC: | 42192-127 |
Proprietary Name: | Halobetasol Propionate |
Non Proprietary Name: | Halobetasol Propionate |
Active Ingredient(s): | .5 mg/g & nbsp; Halobetasol Propionate |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42192-127 |
Labeler Name: | Acella Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077721 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111205 |
Package NDC: | 42192-127-50 |
Package Description: | 1 TUBE in 1 BOX (42192-127-50) > 50 g in 1 TUBE |
NDC Code | 42192-127-50 |
Proprietary Name | Halobetasol Propionate |
Package Description | 1 TUBE in 1 BOX (42192-127-50) > 50 g in 1 TUBE |
Product NDC | 42192-127 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Halobetasol Propionate |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20111205 |
Marketing Category Name | ANDA |
Labeler Name | Acella Pharmaceuticals |
Substance Name | HALOBETASOL PROPIONATE |
Strength Number | .5 |
Strength Unit | mg/g |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |